Recent News

Edge Case Research Secures $7M Towards Improving the Safety and Reliability of Autonomous Vehicles

Wednesday, June 12

Pittsburgh, PA – Edge Case Research (Edge Case), founded by the recognized world leaders in autonomous system safety and autonomous vehicle safety, announced it secured $7 million in investment funding. The investment will expand the development of Hologram, an intelligent safety assessment platform for autonomous vehicle software that operates at the speed of modern machine learning development.

Read More

Exagen and the Lupus Foundation of America Partner on New Initiative to Reduce the Time to an Accurate Lupus Diagnosis

Tuesday, May 07

SAN DIEGO, CA AND WASHINGTON, DC, FEBRUARY 26, 2019 (GLOBE NEWSWIRE) ‐‐ Exagen, a life science company serving the rheumatology specialty, and the Lupus Foundation of America, the national force devoted to solving the mystery of lupus, announced a new initiative to educate those at risk for lupus about the disease and its symptoms in an effort to reduce the time it can take for an accurate lupus diagnosis.

Read More

Cognition Therapeutics Expands Clinical Expertise on Medical Advisory Board with Addition of Drs. Mary Sano and Philip Scheltens

Monday, April 08

Pittsburgh, April 05, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in neurodegenerative diseases and disorders caused by membrane trafficking dysfunction, today announced that Mary Sano, Ph.D. of Mount Sinai School of Medicine and Philip Scheltens, M.D., Ph.D. of the VU Medical Center (VUmc) Alzheimer’s Center in Amsterdam have accepted appointments to the Company’s Medical Advisory Board.

Read More

Cognition Therapeutics Announces Publication of Complete Results from Phase 1 Clinical Trial of Elayta™

Tuesday, February 19

Elayta Crossed Blood Brain Barrier and Reached CNS Levels Associated in Preclinical Studies with Cognitive Improvement

Pittsburgh, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in neurodegenerative disorders, announced today the publication of clinical data from the Company’s Phase 1 trial of Elayta™ (CT1812) in Alzheimer’s & Dementia: Translational Research & Clinical Interventions.

Read More

Why not Pittsburgh for Drug Development? LifeX portfolio company Founder says the time and place are right

Friday, January 04

A LifeX startup company is taking aim at antibiotic-resistant infections in artificial joints, which have few good treatment options for doctors and consequences for the patient that can be painful and costly. Oakland-based Peptilogics Inc. has received approval from Australia’s Therapeutics Goods Administration to begin the first in-human study of its PLG0206 product, which targets prosthetic joint infections. The clinical trial received ethics approval from the Bellberry Human Research Ethics Committee.

Read More

Constellation Brands to Invest $100 Million in Women-Led Start-Ups by 2028

Thursday, December 06

VICTOR, N.Y., Dec. 6, 2018 -- Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today that Constellation Brands Ventures (CBV), the company’s corporate venture capital group, intends to invest $100 million in female-founded or female-led businesses in the beverage alcohol space and adjacent categories by 2028 through a new program, Focus on Female Founders. The company has completed its first investments in two specialty beverage companies: Austin Cocktails and Vivify Beverages.

Read More

PICKUP Picks up $5 Million in Funding

Tuesday, November 13

DALLAS — Pickup, an Uber-like last-mile delivery service for furniture and other large items, has completed a $5 million round of venture capital funding that will speed up expansion of its operations including entry into new markets.

Read More

Here's how Pittsburgh investors scored when Expedia bought a Chicago startup

Wednesday, November 07

Expedia Group’s $21.5 million acquisition of Chicago-based ApartmentJet Inc. translates into a windfall for angel investors in Pittsburgh.

BlueTree Venture Fund and BlueTree Allied Angels will realize a 4.3 times return on its combined $450,000 investment in less than a year, said Catherine Mott, founder, CEO and managing partner of 15-year-old Wexford-based BlueTree Capital Group LLC.

Read More